Exhibits & Sponsors
Join us in paradise! Elevate your brand and connect with over 1,000 attendees by becoming an exhibitor and/or sponsor at the 2025 Annual Meeting in Honolulu, Hawaii.
Take advantage of our exciting sponsorship opportunities for 2025, including:
- Exhibit Space
- Satellite Symposia
- Exhibitor Meeting Suites
- Sponsorship Items
Space is limited – secure your spot today!
THANK YOU TO OUR 2025 SPONSORS!
Platinum Sponsor
Vertex, a global biotechnology company, invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia and continues to advance its research in these diseases. Vertex has a broad and deep clinical pipeline across a range of modalities for other serious diseases like pain, type 1 diabetes and APOL1-mediated kidney disease.
Silver Sponsor
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
Bronze Sponsors
Our mission is to improve the lives of patients by developing novel, best-in-class treatments to address some of the most important unmet patient needs. We aim to develop patient-focused solutions by applying our innovative science and technologies with well-known pharmacology.
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc., is a biotechnology company focused on developing and commercializing innovative therapies in critical care and infectious disease. The company’s commercial portfolio include the first and only antibiotic developed specifically to treat Acinetobacter pathogens in adults; a vasopressor indicated to increase blood pressure in adults with septic or other distributive shock; and a broad-spectrum antibiotic to treat complicated intra-abdominal infections in adults. For more information, visit www.innovivaspecialtytherapeutics.com.
Masimo is a global medical technology company that produces industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and connectivity, automation, telehealth, and consumer solutions. Our mission is to improve patient outcomes, reduce the cost of care, take noninvasive monitoring to new sites and applications, and improve life.
Thank you to our 2025 Exhibitors!
With over $58 million awarded in research grants and programs in anesthesiology since 1986, FAER is dedicated to developing the specialty’s next generation of physician-investigators.
Bold thinking. Bolder actions. We are Medtronic. We lead global healthcare technology and boldly attack themost challenging health problems facing humanity by searchingout and finding solutions. Our Mission — to alleviate pain, restorehealth, and extend life — unites a global team of 95,000+ passionatepeople. In everything we do, we are engineering the extraordinary.
NeuroWave Systems is dedicated to developing innovative brain monitoring and drug delivery medical devices, powered by state-of-the-art signal processing and control engineering technologies. NeuroWave is proud to offer the NeuroSENSE® Monitor, the latest generation of brain monitors for patient-customized anesthesia and sedation delivery. The NeuroSENSE is a unique bilateral brain function monitor with simultaneous independent indices of anesthetic effect for each side of the brain that respond instantaneously to changes in patient state.
Ochsner Health is the leading nonprofit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers. For 13 consecutive years, U.S. News & World Report has recognized Ochsner as the No. 1 hospital in Louisiana. Ochsner’s workforce includes more than 38,000 dedicated team members and over 4,700 employed and affiliated physicians.
Senzime, headquartered in Uppsala, Sweden, is pioneering perioperative monitoring solutions built on over 40 years of research. Our next-generation TetraGraph® enhances patient safety and reduces postoperative complications, setting new standards in perioperative care across 30+ countries. Visit us at the IARS exhibit booth to explore how our science-driven innovations support anesthesiology excellence worldwide. Learn more at senzime.com/nextgen.
The University of Wisconsin Department of Anesthesiology was founded by Ralph M. Waters in 1927 and is the first academic anesthesiology department in the United States. Our mission today reflects the same noble vision established by Dr. Waters: Excellence in clinical practice, education, and research. We invite you to visit us online and learn more about us: www.anesthesia.wisc.edu